Pascal Hammel, MD
Hôpital Beaujon
3
3
0
N/A
0
7
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (3)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Renuka Iyer
Roswell Park Cancer Institute
Shared therapeutic areas:
Worked with same sponsors:
Eileen O'Reilly, MD
Memorial Sloan Kettering Cancer Center
Shared therapeutic areas:
Worked with same sponsors:
Guopei Luo, MD
Fudan University
Shared therapeutic areas:
Inmaculada Gallego, MD, PhD
Hospitales Universitarios Virgen del Rocío
Shared therapeutic areas:
Carmen Guillén, MD
Hospital Universitario Ramon y Cajal
Shared therapeutic areas:
George Albert Fisher M.D. Ph.D.
Stanford University
Shared therapeutic areas:
Francois Benard, MD
BC Cancer
Shared therapeutic areas:
Steven A Rosenberg, M.D.
National Cancer Institute (NCI)
Shared therapeutic areas:
Brennan Spiegel, MD, MSHS
Cedars-Sinai Medical Center
Shared therapeutic areas:
Alana TH Nguyen, MD, PhD
Weill Medical College of Cornell University
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (3)
Showing 3 of 3 trials
Maintenance With Olaparib or Selumetinib + Durvaluma for m-PDAC Guided by BRCAness and KRAS Status.
Evaluation of an Adapted Physical Activity Program in Patients With Unresectable Pancreatic Cancer
A Study of Sunitinib Versus Placebo in Combination With Lanreotide in Patients With Progressive Advanced/Metastatic Midgut Carcinoid Tumors
All 3 trials loaded